Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

BRCA1/2 carriers and endocrine risk modifiers.

Endocrine-related cancer - 1 Dec 1999

Eeles R, Kadouri L

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to Chemoprevention
Share to BRCA2 Protein
Share to Genes, BRCA1

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Heterozygote

Share to Neoplasm Proteins

Share to Neoplasms, Hormone-Dependent

Share to Ovarian Neoplasms

Source

Identifiers

PMID: 10730905
DOI: 10.1677/erc.0.0060521

Genes

BRCA1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

BRCA1/2 carriers and endocrine risk modifiers.PMID 10730905Read ↗

Cancer risks for men with BRCA1/2 mutationsSemantic proximity Read ↗

Modifiers of breast and ovarian cancer risks for BRCA1 and BRCA2 mutation carriers.Semantic proximity Read ↗

BRCA1 and BRCA2 - update and implications on the genetics of breast cancer: a clinical perspective.Semantic proximity Read ↗

BRCA1 and BRCA2.Semantic proximity Read ↗

Emerging cancer risks in BRCA2 pathogenic germline variant carriers.Semantic proximity Read ↗

Germline Pathogenic Variants in BRCA1 and BRCA2: Malignancies Beyond Female Breast and Ovarian Cancers.Semantic proximity Read ↗

BRCA-associated cancer risk: molecular biology and clinical practice.Semantic proximity Read ↗

Epidemiology of breast cancer among BRCA mutation carriers: an overview.Semantic proximity Read ↗

BRCA screening.Semantic proximity Read ↗

Genetic testing of breast and ovarian cancer patients: clinical characteristics and hormonal risk modifiers.Semantic proximity Read ↗

Effects of Endocrine Interventions Targeting ERα or PR on Breast Cancer Risk in the General Population and Carriers of BRCA1/2 Pathogenic Variants.Semantic proximity Read ↗

BRCA1 and BRCA2 mutation carriers as potential candidates for chemoprevention trials.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.